Trial Profile
A trial to examine the impact of denosumab on diabetes, in terms of whether it delays the development of diabetes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Jun 2016
Price :
$35
*
At a glance
- Drugs Denosumab (Primary) ; Etidronic acid; Risedronic acid; Zoledronic acid
- Indications Diabetes mellitus
- Focus Therapeutic Use
- 01 Jun 2016 New trial record
- 25 May 2016 Results presented at the 21st Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research